U.S. pharma giant copyright scrapped two experimental weight loss products past year—a as soon as-daily capsule, lotiglipron, due to elevated liver enzymes and a twice-every day tablet, danuglipron, on account of robust side effects—but CEO Albert Bourla has explained the company is decided to “Participate in and win” within the being overw